FERI (Luxembourg) S.A.’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$6.26M Buy
11,970
+5,430
+83% +$2.78M 0.84% 37
2026
Q2
$3.25M Buy
+6,540
New +$2.9M 0.52% 57
2025
Q4
– Sell
-8,110
Closed -$3.18M – 97
2025
Q3
$3.18M Sell
8,110
-180
-2% -$75.2K 0.92% 34
2025
Q2
$3.69M Buy
+8,290
New +$3.82M 1.18% 26
2025
Q1
– Sell
-1,020
Closed -$411K – 123
2024
Q4
$411K Sell
1,020
-590
-37% -$273K 0.23% 99
2024
Q3
$749K Buy
1,610
+620
+63% +$298K 0.43% 81
2024
Q2
$464K Buy
990
+413
+72% +$179K 0.3% 76
2024
Q1
$241K Hold
577
– – 0.17% 106
2023
Q4
$235K Buy
+577
New +$213K 0.17% 106

Other funds holding VRTX

FERI (Luxembourg) S.A.'s VRTX Position: Q3 2026 in Review

FERI (Luxembourg) S.A. increased its Vertex Pharmaceuticals (VRTX) stake by 83% in Q3 2026, buying an estimated $2.78M and bringing the position to 11,970 shares worth $6.26M. The position accounts for 0.84% of the portfolio, ranked #37.

FERI (Luxembourg) S.A. first reported a position in VRTX in Q4 2023 and has held it in 9 quarters since. 1,688 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.

  • FERI (Luxembourg) S.A. held 11,970 shares of Vertex Pharmaceuticals worth $6.26M as of Q3 2026.
  • FERI (Luxembourg) S.A. bought 5,430 Vertex Pharmaceuticals shares in Q3 2026, an estimated $2.78M.
  • Vertex Pharmaceuticals made up 0.84% of FERI (Luxembourg) S.A.'s portfolio in Q3 2026, its #37 holding.
  • FERI (Luxembourg) S.A. first reported a position in Vertex Pharmaceuticals in Q4 2023 and has held it in 9 quarters since.
  • 1,688 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.

Based on FERI (Luxembourg) S.A.'s 13F filing for Q3 2026, filed 16 Nov 2026.